Turner’s syndrome  is associated with growth retardation during infancy and childhood with absence of the pubertal growth spurt.

The adult stature of untreated Turner’s syndrome  individuals is approximately 20cm shorter than their target height. Growth hormone (GH) therapy aimed at achieving the maximal adult height is usually instituted in childhood and completed in early adolescence.

Where GH therapy has not been completed, continued paediatric endocrinologist input is necessary for prescription and monitoring of GH treatment.

Psychological issues relating to persisting short stature may be an important consideration for the women involved.

Content created June 04, 2007